Virologic Outcomes with Tenofovir-Lamivudine-Dolutegravir for PI-Based Second-Line ART Failure

Conference Reports for NATAP

Conference on Retroviruses
and Opportunistic Infections
Denver, Colorado
March 3-6 2024


Virologic Outcomes with Tenofovir-Lamivudine-Dolutegravir for PI-Based Second-Line ART Failure

	CROI 2024 March 3-6 Denver Ying Zhao1,2, Jacqueline Voget3, Isaac Singini4, Zaayid Omar2, Vanessa Mudaly3, Andrew Boulle5, Gary Maartens2,6, Graeme Meintjes1,2